The healthcare community is intently watching this groundbreaking treatment, a dual-action modulator targeting both glucose metabolism and GIP. Initial data suggest it appears to offer significant gains in reducing body weight compared to available treatments, conceivably representing a important advance in the fight of weight-related illnesses.… Read More